American journal of therapeutics
-
Comparative Study
Comparative Clinical Outcomes of Edoxaban in Adults With Nonvalvular Atrial Fibrillation.
A critical appraisal of all pooled evidence regarding novel oral anticoagulants (NOACs) for stroke prevention regardless of publication status or study design has not been conducted yet. Being the latest addition to NOACs, the data on edoxaban are especially scarce. ⋯ Edoxaban is a welcome addition to the NOAC's armamentarium. However, the comparative data with other novel NOACs are mostly nonexisting, and urgently needed for better individual patient assessment.